Table 5.
Gametocyte carriage pre- and posttreatment of malarious children with AA, AL, or DHP
Posttreatment (%) | ||||||
Treatment | Pretreatment (day 0) (%) | Day 7 | Day 14 | Day 21 | Day 28 | P value* |
AA | 20/292 (6.8) | 14/283 (4.9) | 6/285 (2.1) | 3/276 (1.1) | 1/274 (0.4) | < 0.0001 |
AL | 9/301 (3) | 5/295 (1.7) | 1/289 (0.3) | 2/280 (0.7) | 0/275 (0) | 0.001 |
DHP | 18/317 (5.8) | 5/308 (1.6) | 1/307 (0.3) | 2/300 (0.7) | 2/297 (0.7) | < 0.0001 |
All treatments | 47/910 (5.2) | 24/886 (2.7) | 8/881 (0.9) | 7/856 (0.8) | 3/846 (0.4) | < 0.0001 |
P value† | 0.08 | 0.03 | 0.046 | 0.84 | 1.0‡ | – |
AA = artesunate–amodiaquine; AL = artemether–lumefantrine; DHP = dihydroartemisinin–piperaquine.
Test for trend.
Test of proportions.
Children treated with artemether–lumefantrine were not included in the comparison.